CN111675728A - 基于苯硒醚基团专一响应Cys的荧光探针、制备方法及应用 - Google Patents
基于苯硒醚基团专一响应Cys的荧光探针、制备方法及应用 Download PDFInfo
- Publication number
- CN111675728A CN111675728A CN202010553338.5A CN202010553338A CN111675728A CN 111675728 A CN111675728 A CN 111675728A CN 202010553338 A CN202010553338 A CN 202010553338A CN 111675728 A CN111675728 A CN 111675728A
- Authority
- CN
- China
- Prior art keywords
- cys
- fluorescent probe
- compound
- phenylselenol
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- YWBHROUQJYHSOR-UHFFFAOYSA-N $l^{1}-selanylbenzene Chemical group [Se]C1=CC=CC=C1 YWBHROUQJYHSOR-UHFFFAOYSA-N 0.000 title claims abstract description 21
- 230000004044 response Effects 0.000 title claims abstract description 17
- 239000000523 sample Substances 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 30
- 238000004440 column chromatography Methods 0.000 claims description 20
- 238000000926 separation method Methods 0.000 claims description 19
- 229940126214 compound 3 Drugs 0.000 claims description 16
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 15
- 229940125904 compound 1 Drugs 0.000 claims description 15
- 229940125782 compound 2 Drugs 0.000 claims description 15
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 13
- -1 p-toluenesulfonate oxime ester Chemical class 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 230000000536 complexating effect Effects 0.000 claims description 10
- 239000005457 ice water Substances 0.000 claims description 10
- 239000012046 mixed solvent Substances 0.000 claims description 10
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 10
- 238000010791 quenching Methods 0.000 claims description 10
- 230000000171 quenching effect Effects 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- WRRZKDVBPZBNJN-ONEGZZNKSA-N (e)-4-(4-methoxyphenyl)but-3-en-2-one Chemical compound COC1=CC=C(\C=C\C(C)=O)C=C1 WRRZKDVBPZBNJN-ONEGZZNKSA-N 0.000 claims description 6
- YWWZCHLUQSHMCL-UHFFFAOYSA-N diphenyl diselenide Chemical compound C=1C=CC=CC=1[Se][Se]C1=CC=CC=C1 YWWZCHLUQSHMCL-UHFFFAOYSA-N 0.000 claims description 6
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 claims description 6
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 claims description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 5
- 230000009467 reduction Effects 0.000 claims description 5
- 239000012312 sodium hydride Substances 0.000 claims description 5
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 4
- 238000011895 specific detection Methods 0.000 claims description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
- 238000001514 detection method Methods 0.000 abstract description 9
- 150000001413 amino acids Chemical class 0.000 abstract description 6
- 230000008859 change Effects 0.000 abstract description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 239000000975 dye Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000000269 nucleophilic effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 238000006462 rearrangement reaction Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 14
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 229960003180 glutathione Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 150000003568 thioethers Chemical class 0.000 description 4
- 150000003573 thiols Chemical class 0.000 description 4
- YPWSLBHSMIKTPR-UHFFFAOYSA-N Cystathionine Natural products OC(=O)C(N)CCSSCC(N)C(O)=O YPWSLBHSMIKTPR-UHFFFAOYSA-N 0.000 description 3
- ILRYLPWNYFXEMH-UHFFFAOYSA-N D-cystathionine Natural products OC(=O)C(N)CCSCC(N)C(O)=O ILRYLPWNYFXEMH-UHFFFAOYSA-N 0.000 description 3
- ILRYLPWNYFXEMH-WHFBIAKZSA-N L-cystathionine Chemical compound [O-]C(=O)[C@@H]([NH3+])CCSC[C@H]([NH3+])C([O-])=O ILRYLPWNYFXEMH-WHFBIAKZSA-N 0.000 description 3
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010226 confocal imaging Methods 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 239000012434 nucleophilic reagent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
- C09K2211/1055—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
本发明提供了一种基于苯硒醚基团专一响应Cys的荧光探针、制备方法及应用。本探针选择BODIPY染料为荧光团，苯硒醚为识别团。检测机制是Cys同苯硒醚发生亲核取代‑重排反应，引起荧光信号变化。上述探针通过紫外和荧光光谱仪检测Cys且不受其他氨基酸和活性氧类的干扰，该检测过程简便、快速、灵敏，检测限为33 nM。更重要的是该探针可以检测细胞中Cys，在生物监测领域具有良好应用前景。
Description
技术领域
本发明涉及荧光探针，具体涉及一种基于苯硒醚基团专一响应Cys的荧光探针、制备方法及应用。
背景技术
生物硫化物对动植物和微观生命体代谢，食品加工等方面发挥着重要作用。小分子硫醇是生物硫化物的一部分其包括：半胱氨酸(Cys)，同型半胱氨酸(Hcy)和谷胱甘肽(GSH)。三种硫醇的浓度异常可能导致多种疾病，如肝脏损伤，心血管疾病，阿尔兹海默症，癌症等。在动物体内半胱氨酸(Cys)是一种蛋白质原性、半必需氨基酸，通过在折叠的蛋白质中提供二硫键来稳定蛋白质结构，增加蛋白质的刚性，调节蛋白质的功能。Cys合成的前体是Hcy，蛋氨酸转化为同型半胱氨酸，再与丝氨酸结合形成不对称的硫醚半胱氨酸Hcy结合丝氨酸在胱硫醚b-合酶(CBS)的作用下形成胱硫醚，之后在胱硫醚g-裂解酶(CSE)的作用下裂解成Cys。同时它还是GSH，牛磺酸和乙酰辅酶A合成的前体氨基酸。除此之外，Cys还可以从食物中获取，Cys存在于高蛋白食物中，包括肉类、鸡蛋、奶制品等。并且Cys已被粮农组织联合专家委员会(JECFA)指定为调味剂，因此，Cys的专一性检测非常重要。
但是，由于硫醇本身的结构相似性，都具有相同的活性位点巯基和胺基，特别是Cys和Hcy两者仅相差一个亚甲基的区别。所以实现三者区分仍是一个巨大的挑战。苯硒醚基团是易于离去的基团，容易受到亲核试剂的进攻，发生取代反应。而将苯硒醚作为检测团利用巯基的强亲核性对于活性硫化物报道非常少，特别是专一性识别Cys的探针还未曾报道。红色荧光探针因其长发射波长和强组织穿透性而众所周知。因此，开发基于苯硒醚为检测基团专一性响应动物细胞Cys的红色荧光探针具有重要意义。
发明内容
本发明提出了一种基于苯硒醚基团专一响应Cys的荧光探针、制备方法及应用，该探针制备方法操作方便，原料易得，能够实现细胞内Cys的专一性检测。
实现本发明的技术方案是：
一种基于苯硒醚基团专一响应Cys的荧光探针，探针的结构式为：
基于苯硒醚基团专一响应Cys的荧光探针的制备方法，步骤如下：
（1）N2保护冰水浴下，氢化钠加入到四氢呋喃溶剂中混合得到混合溶剂，将丙酮基对甲苯磺酸肟酯与对甲氧苯乙烯基甲基酮按照当量为1：2～3的比例溶于混合溶剂中，50℃反应4小时，冰水淬灭，二氯甲烷萃取，柱层析分离得到化合物1；
化合物1的结构式如下：
；
（2）步骤（1）制得的化合物1溶于四氢呋喃中，将N,N-二异丙基乙胺和三光气或硫光气按照当量为1：（1～1.5）的比例加入，25℃搅拌1-1.5h，然后减压去除溶剂，柱层析分离得到化合物2；
化合物2的结构式如下：
，
（3）将步骤（2）所得化合物2溶于二氯甲烷中，加入1.5当量的三氯氧磷反应过夜，之后加碱和三氟化硼乙醚按照当量为6：（8～10.5）加入上述体系中络合，25 ℃下络合4～6小时，柱层析分离得到化合物3；
化合物3的结构式如下：
，
（4）将二苯基二硒醚和四氢铝锂按照当量为1：2的比例溶于乙醇中还原，加入2～2.5当量的化合物3室温反应1～1.5小时，然后淬灭减压去除溶剂，残留物柱层析分离得到探针BDP-Se-3。
所述的制备方法制备的探针在专一检测Cys中的应用。
荧光探针的合成路线如下：
本发明基于苯硒醚作为响应基团用于专一检测Cys的荧光探针，该探针在溶液测试中，利用紫外和荧光光谱可判断出探针与Cys反应时间，浓度依赖性关系；在通过选择性和抗干扰能力测试观察出，探针可专一性检测Cys，不与活性氧化物反应且抗干扰能力强；并且探针的pH稳定性强，细胞毒性小。还可通过共聚焦荧光显微镜达到对HeLa细胞中的Cys检测的目的。
本发明的有益效果是：
（1）本发明一种利用苯硒醚作为响应基团专一性检测Cys的荧光探针，合成方法简单，操作方便；
（2）本发明的检测方法可以实现Cys专一性检测，而且不受其他氨基酸和活性氧化物类的干扰；
（3）本发明检测信号明显，为类近红外荧光增强型荧光探针。
附图说明
为了更清楚地说明本发明实施例或现有技术中的技术方案，下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍，显而易见地，下面描述中的附图仅仅是本发明的一些实施例，对于本领域普通技术人员来讲，在不付出创造性劳动的前提下，还可以根据这些附图获得其他的附图。
图1为荧光探针BDP-Se-3的核磁氢谱图；
图2为荧光探针BDP-Se-3的核磁碳谱图；
图3为荧光探针BDP-Se-3与Cys作用的时间紫外变化；
图4为荧光探针BDP-Se-3与Cys作用的时间荧光变化；
图5为荧光探针BDP-Se-3测定Cys浓度滴定实验荧光变化；
图6为荧光最强发射波长610nm与Cys的浓度线性拟合图；
图7为常见氨基酸对探针BDP-Se-3检测Cys的荧光选择性；
图8为常见氨基酸对探针BDP-Se-3检测Cys的荧光干扰性；
图9为荧光探针BDP-Se-3和探针加Cys在不同pH缓冲溶液中最大荧光强度变化图；
图10为探针BDP-Se-3检测Cys的细胞毒性；
图11为荧光探针BDP-Se-3检测Cys HeLa细胞成像图。
具体实施方式
下面将结合本发明实施例，对本发明的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有付出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
探针的制备步骤如下：
（1）化合物1的制备
N2保护冰水浴下，氢化钠加入到四氢呋喃溶剂中混合得到混合溶剂，将丙酮基对甲苯磺酸肟酯与对甲氧苯乙烯基甲基酮按照当量为1：2的比例溶于混合溶剂中，50℃反应4小时，冰水淬灭，二氯甲烷萃取，柱层析分离得到化合物1；
1H NMR (400 MHz, DMSO) δ 10.70 (s, 1H), 7.35 (d, J = 8.4 Hz, 2H), 6.89(d, J = 8.6 Hz, 2H), 6.76 (q, J = 16.5 Hz, 2H), 6.54 (s, 1H), 6.02 (s, 1H),3.75 (s, 3H), 2.01 (s, 3H)。
（2）化合物2的制备
将化合物1溶于四氢呋喃中，将N,N-二异丙基乙胺和三光气或硫光气按照当量为1：1的比例加入，25℃搅拌1h，然后减压去除溶剂，柱层析分离得到化合物2；
1H NMR (300 MHz, DMSO) δ 11.34 (s, 2H), 7.42 (d, J = 8.7 Hz, 5H), 7.14(d, J = 16.5 Hz, 3H), 7.00 – 6.89 (m, 7H), 6.34 (s, 2H), 3.77 (s, 6H), 2.11(s, 6H)。
（3）化合物3的制备
将化合物2溶于二氯甲烷，加入1.5当量的三氯氧磷反应过夜，之后加碱和三氟化硼乙醚按照当量为6：8加入上述体系中络合，25 ℃下络合4小时，柱层析分离得到化合物3；
1H NMR (400 MHz, CDCl3) δ 7.60 – 7.49 (m, 7H), 7.22 (s, 1H), 6.93 (d, J =8.6 Hz, 4H), 6.71 (s, 2H), 3.85 (s, 6H), 2.52 (s, 6H)。
（4）BDP-Se-3的制备
将二苯基二硒醚和四氢铝锂按照当量为1：2的比例溶于乙醇中还原，加入2当量的化合物3室温反应1小时，然后淬灭减压去除溶剂，残留物柱层析分离得到探针BDP-Se-3。
1H NMR (400 MHz, CDCl3): δ7.62 (s, 1H), 7.59 (d, J = 8.6 Hz, 5H), 7.29(d, J = 7.5 Hz, 3H), 7.23 (s, 3H), 7.18 (d, J = 7.0 Hz, 1H), 6.94 (d, J = 8.7Hz, 14H), 6.71(s, 2H), 3.86 (s, 6H), 2.50 (s, 6H)。13C NMR (101 MHz, CDCl3) δ160.61, 152.70, 143.72, 136.78, 133.81, 129.82, 129.57, 129.22, 128.22,126.38, 119.07, 117.18, 114.34, 55.40, 18.20。
实施例2
探针的制备步骤如下：
（1）化合物1的制备
N2保护冰水浴下，氢化钠加入到四氢呋喃溶剂中混合得到混合溶剂，将丙酮基对甲苯磺酸肟酯与对甲氧苯乙烯基甲基酮按照当量为1：2.5的比例溶于混合溶剂中，50℃反应4小时，冰水淬灭，二氯甲烷萃取，柱层析分离得到化合物1；
（2）化合物2的制备
将化合物1溶于四氢呋喃中，将N,N-二异丙基乙胺和三光气或硫光气按照当量为1：1.3的比例加入，25℃搅拌1-1.5h，然后减压去除溶剂，柱层析分离得到化合物2；
（3）化合物3的制备
将化合物2溶于二氯甲烷，加入1.5当量的三氯氧磷反应过夜，之后加碱和三氟化硼乙醚按照当量为6：9加入上述体系中络合，25 ℃下络合5小时，柱层析分离得到化合物3；
（4）BDP-Se-3的制备
将二苯基二硒醚和四氢铝锂按照当量为1：2的比例溶于乙醇中还原，加入2.3当量的化合物3室温反应1.3小时，然后淬灭减压去除溶剂，残留物柱层析分离得到探针BDP-Se-3。
实施例3
探针的制备步骤如下：
（1）化合物1的制备
N2保护冰水浴下，氢化钠加入到四氢呋喃溶剂中混合得到混合溶剂，将丙酮基对甲苯磺酸肟酯与对甲氧苯乙烯基甲基酮按照当量为1：3的比例溶于混合溶剂中，50℃反应4小时，冰水淬灭，二氯甲烷萃取，柱层析分离得到化合物1；
（2）化合物2的制备
将化合物1溶于四氢呋喃中，将N,N-二异丙基乙胺和三光气或硫光气按照当量为1：1.5的比例加入，25℃搅拌1.5h，然后减压去除溶剂，柱层析分离得到化合物2；
（3）化合物3的制备
将化合物2溶于二氯甲烷，加入1.5当量的三氯氧磷反应过夜，之后加碱和三氟化硼乙醚按照当量为6：10.5加入上述体系中络合，25 ℃下络合6小时，柱层析分离得到化合物3；
（4）BDP-Se-3的制备
将二苯基二硒醚和四氢铝锂按照当量为1：2的比例溶于乙醇中还原，加入2.5当量的化合物3室温反应1.5小时，然后淬灭减压去除溶剂，残留物柱层析分离得到探针BDP-Se-3。
实施例4
溶液中检测Cys的荧光探针BDP-Se-3的反应时间测试：
用二甲基亚砜(DMSO)配制1 mM BDP-Se-3的荧光探针储备液；探针BDP-Se-3（10 µM）与Cys（100 µM）在溶液体系为CH3CN/PBS缓冲液(v/v＝1/1，pH＝7.4)中进行反应，如图3所示，从紫外吸收图谱观察BDP-Se-3在675 nm处的吸收峰伴随着时间的推移逐渐下降，并在10min内下降到最低；而新生成的545 nm处紫外吸收峰逐渐增大至最高值，反应前后的吸收峰发生了130 nm的蓝移。同时，在荧光图谱上可观察到，在用525 nm的激发下，613 nm处出现一个新的荧光发射峰并增强约80倍(图4所示)。
实施例5
溶液中检测Cys的荧光探针BDP-Se-3的浓度滴定测试以及浓度线性关系：
在浓度滴定实验中，发现随着Cys的浓度逐渐增加，613 nm处的荧光峰也逐渐增强，其荧光强度在Cys浓度至100 µM时达到最。(见图5所示)。
以Cys浓度为横坐标，探针BDP-Se-3在613 nm处的荧光强度为纵坐标，绘制图并进行线性拟合，得到该探针的线性回归方程为：Y = 14.4 X + 3.89，线性相关系数R2 =0.999并计算出检测限为33 nM。(见图6所示)。
实施例6
干扰性和抗干扰性离子实验：
在不同的荧光比色皿中，分别加入4 mL CH3CN/PBS缓冲液(v/v＝1/1，pH＝7.4)和40μL荧光探针储备液，如图7所示，当探针BDP-Se-3分别加入上述选择的氨基酸，活性硫化物以及活性氧化物分析物种（100 µM）后（1: Cys; 2: Hcy; 3: GSH; 4: Ala; 5: Gln; 6:Ile; 7: Met; 8: Arg; 9: His; 10: Tyr; 11: Asp; 12: Glu; 13: Leu; 14: Gly; 15:Phe; 16: Lys; 17:Thr; 18: Ser; 19: Pro; 20: Try; 21: SO3 2ˉ; 22: S2O3 2ˉ; 23:S2O4 2ˉ; 24: S2O5 2ˉ; 25: HSO3ˉ; 26: NaHS; 27: NO·; 28: TBHP; 29: HOCl; 30:H2O2 ; 31: 1O2 ; 32: ONOO−），探针BDP-Se-3可以对Cys进行专一性识别，并在613 nm处出现明亮的红色荧光，而跟Hcy/GSH和其它种类分析物反应后没有荧光出现，因此，探针可以实现专一性响应Cys。当BDP-Se-3（10 µM）在分别加入上述分析物（0: blank; 1: Hcy; 2:GSH; 3: Ala; 4: Gln; 5: Ile; 6: Met; 7: Arg; 8: His; 9: Tyr; 10: Asp; 11:Glu; 12: Leu; 13: Gly; 14: Phe; 15: Lys; 16:Thr; 17: Ser; 18: Pro; 19: Try;20: SO3 2ˉ; 21: S2O3 2ˉ; 22: S2O4 2ˉ; 23: S2O5 2ˉ; 24: HSO3ˉ; 25: NaHS; 26: NO·; 27:TBHP; 28: H2O2 ; 29: 1O2）后再加入100 µM Cys反应10分钟后，可以看出Cys在与各种分析物共存情况下，BDP-Se-3在复杂的溶液体系内依然能够专一性检测到Cys，且荧光程度较强。实验证明，BDP-Se-3能够在响应Cys时不受其它物质的干扰(见图8所示)。
实施例7
pH值的响应性实验：
将探针BDP-Se-3溶于二甲基亚砜中得到10mM探针母液，配置pH为6.0、6.4、6.8、7.2、7.6、8.0的磷酸二氢钾和氢氧化钠缓冲溶液，对探针以及探针和Cys反应后荧光强度的变化进行了研究。
结果如图9所示，探针荧光强度在pH值为6.0‒8.0的溶液中基本保持不变；在加入Cys后，随着pH值的不断升高，其位于613 nm处荧光强度不断增强，且在生理范围7.2‒8.0的pH值下，荧光强度最强。实验证明探针BDP-Se-3能够适应生物体内的pH环境。
实施例8
MTT细胞毒性实验：
利用探针BDP-Se-3对HeLa细胞的MTT细胞毒性实验，结果如图10所示。HeLa细胞用含有不同浓度的探针（1.25, 2.5, 5.0, 10, 20 μM）培养液孵育后，计算细胞的存活百分比。结果如图9所示，低浓度下细胞存活率可高达90%，探针几乎没有细胞毒性。
实施例9
检测半胱氨酸的荧光探针对HeLa细胞内Cys的检测性能测试；
检测Cys的荧光探针BDP-Se-3对人体宫颈癌（HeLa）细胞中Cys的荧光共聚焦成像。结果如图11所示，(a)明场和(b)BDP-Se-3（10 μM）和HeLa细胞一起孵育30分钟后，再用PBS缓冲液洗涤三次后的显微镜下荧光成像；(d)明场和(e)HeLa细胞先用5 mM的NEM孵育40分钟，用PBS缓冲液洗涤三次，BDP-Se-3（10 μM）再与细胞共孵育30分钟；(c)和(f)为共聚焦荧光与明场的重叠。通过共聚焦红色通道观察，检测Cys的荧光探针在HeLa细胞中产生明亮的红色荧光；对照组实验中，将细胞先与NEM(N-乙基马来酰亚胺，生物硫醇掩蔽剂)共同孵育然后再与BDP-Se-3共同孵育，由成像实验结果可以观察红色通道荧光响应微弱。由此说明探针可以检测细胞内源性Cys。该结果也表明，本发明的荧光探针具有检测HeLa细胞内Cys的良好应用前景。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明，凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (10)
1.一种基于苯硒醚基团专一响应Cys的荧光探针，其特征在于，探针的结构式为：
2.权利要求1所述的基于苯硒醚基团专一响应Cys的荧光探针的制备方法，其特征在于步骤如下：
（1）N2保护冰水浴下，将丙酮基对甲苯磺酸肟酯与对甲氧苯乙烯基甲基酮溶于混合溶剂中，50℃反应4小时，冰水淬灭，二氯甲烷萃取，柱层析分离得到化合物1；
（2）步骤（1）制得的化合物1溶于四氢呋喃中，加入N,N-二异丙基乙胺和三光气或硫光气，室温搅拌，然后减压去除溶剂，柱层析分离得到化合物2；
（3）将步骤（2）所得化合物2溶于二氯甲烷中，加入三氯氧磷反应过夜，之后加碱和三氟化硼乙醚络合，柱层析分离得到化合物3；
（4）将二苯基二硒醚和四氢铝锂溶于乙醇中还原，加入化合物3室温反应，然后淬灭减压去除溶剂，残留物柱层析分离得到探针BDP-Se-3。
3.根据权利要求1所述的基于苯硒醚基团专一响应Cys的荧光探针的制备方法，其特征在于，所述步骤（1）中化合物1的结构式如下：
。
4.根据权利要求1所述的基于苯硒醚基团专一响应Cys的荧光探针的制备方法，其特征在于，所述步骤（2）中化合物2的结构式如下：
。
5.根据权利要求1所述的基于苯硒醚基团专一响应Cys的荧光探针的制备方法，其特征在于，所述步骤（3）中化合物3的结构式如下：
。
6.根据权利要求1所述的基于苯硒醚基团专一响应Cys的荧光探针的制备方法，其特征在于：所述步骤（1）中混合溶剂为氢化钠加入到四氢呋喃溶剂中混合得到，丙酮基对甲苯磺酸肟酯与对甲氧苯乙烯基甲基酮按照当量为1：（2-3）的比例溶于混合溶剂中。
7.根据权利要求1所述的基于苯硒醚基团专一响应Cys的荧光探针的制备方法，其特征在于：所述步骤（2）中N,N-二异丙基乙胺和三光气或硫光气按照当量为1：（1～1.5）比例添加，室温搅拌1-1.5h。
8.根据权利要求1所述的基于苯硒醚基团专一响应Cys的荧光探针的制备方法，其特征在于：所述步骤（3）中碱为N,N-二异丙基乙胺或三乙胺，碱与三氟化硼乙醚按照当量为6：（8～10.5）添加，室温络合4-6h。
9.根据权利要求1所述的基于苯硒醚基团专一响应Cys的荧光探针的制备方法，其特征在于：所述步骤（4）中二苯基二硒醚和四氢铝锂按照当量为1:2的比例混合溶解，加入2-2.5当量化合物3室温反应1-1.5h。
10.权利要求2-9任一项所述的制备方法制备的探针在专一检测Cys中的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010553338.5A CN111675728B (zh) | 2020-06-17 | 2020-06-17 | 基于苯硒醚基团专一响应Cys的荧光探针、制备方法及应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010553338.5A CN111675728B (zh) | 2020-06-17 | 2020-06-17 | 基于苯硒醚基团专一响应Cys的荧光探针、制备方法及应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111675728A true CN111675728A (zh) | 2020-09-18 |
| CN111675728B CN111675728B (zh) | 2021-04-20 |
Family
ID=72455331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010553338.5A Active CN111675728B (zh) | 2020-06-17 | 2020-06-17 | 基于苯硒醚基团专一响应Cys的荧光探针、制备方法及应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111675728B (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112745340A (zh) * | 2020-12-30 | 2021-05-04 | 河南大学 | 基于bodipy染料靶向溶酶体选择性检测h2s的荧光探针、制备及应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103571458A (zh) * | 2012-08-02 | 2014-02-12 | 中国科学院大连化学物理研究所 | 一类含硒氟硼染料荧光探针及其在ClO-检测上的应用 |
-
2020
- 2020-06-17 CN CN202010553338.5A patent/CN111675728B/zh active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103571458A (zh) * | 2012-08-02 | 2014-02-12 | 中国科学院大连化学物理研究所 | 一类含硒氟硼染料荧光探针及其在ClO-检测上的应用 |
Non-Patent Citations (3)
| Title |
|---|
| CHENGJUN WANG ET AL.: "A novel near-infrared styryl-BODIPY fluorescent probe for discrimination ofGSH and its application in living cells", 《DYES AND PIGMENTS》 * |
| JIAN ZHANG ET AL.: "Meso-heteroaryl BODIPY dyes as dual-responsive fluorescent probes probesfor discrimination of Cys from Hcy and GSH", 《SENSORS AND ACTUATORS B: CHEMICAL》 * |
| JINHUA GAO ET AL.: "Development of Lysosome-Targeted Fluorescent Probes for Cys by Regulating the Boron-dipyrromethene (BODIPY) Molecular Structure", 《CHEMISTRY A EUROPEAN JOURNAL》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112745340A (zh) * | 2020-12-30 | 2021-05-04 | 河南大学 | 基于bodipy染料靶向溶酶体选择性检测h2s的荧光探针、制备及应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111675728B (zh) | 2021-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110540837B (zh) | 一种过氧化氢近红外荧光探针的制备和应用 | |
| CN110563689B (zh) | 一种特异性检测活细胞中的半胱氨酸的长波长发射荧光探针及其制备方法和应用 | |
| CN109438319B (zh) | 一种检测亮氨酸氨肽酶的化合物及其制备方法和应用 | |
| CN106929006B (zh) | 一种以萘酰亚胺为母核的识别半胱氨酸和同型半胱氨酸荧光探针及其制备与应用 | |
| CN109608474B (zh) | 一种检测酪氨酸酶的化合物及其制备方法和应用 | |
| CN110878049B (zh) | 一种特异性分析高尔基体中硫化氢的荧光探针制备与应用 | |
| Anila et al. | A Cysteine-Specific Fluorescent Switch for Monitoring Oxidative Stress and Quantification of Aminoacylase-1 in Blood Serum | |
| CN110128440A (zh) | 一种检测水溶性环境中生物硫醇的荧光探针及其制备方法和应用 | |
| CN111675728B (zh) | 基于苯硒醚基团专一响应Cys的荧光探针、制备方法及应用 | |
| CN111892552A (zh) | 一种三苯胺衍生物及其制备方法和在对硫化氢的双通道荧光检测中的应用 | |
| CN112745340B (zh) | 基于bodipy染料靶向溶酶体选择性检测h2s的荧光探针、制备及应用 | |
| Cui et al. | A turn-on fluorescent probe based on indolizine for the detection of sulfite | |
| CN111518066B (zh) | 用于识别次氯酸根和亚硫酸氢根的双功能荧光探针及其制备方法和应用 | |
| CN110467578A (zh) | 一种人半胱氨酸荧光探针及其制法和用途 | |
| CN108383774A (zh) | 一种基于端基炔酮的半胱氨酸荧光探针及其制备和应用 | |
| CN109608495B (zh) | 一种检测hno的化合物及其制备方法和应用 | |
| CN108033911B (zh) | 一种二氧化硫/亚硫酸（氢）盐的溶酶体靶向荧光探针 | |
| CN115557853A (zh) | 一种亮氨酸氨基肽酶荧光探针及其制备方法和应用 | |
| CN113200975B (zh) | 基于靛红衍生物专一响应onoo-的水溶性荧光探针、制备方法及应用 | |
| EP2258692A1 (en) | Thiol detection method | |
| CN111039866B (zh) | 一种靶向高尔基体的硫化氢荧光探针、制备方法与应用 | |
| CN114634464A (zh) | 一种用于检测次氯酸的溶酶体靶向近红外荧光探针及其制备方法和应用 | |
| CN112457360B (zh) | 一种肝靶向的过氧亚硝酸根荧光探针及制备方法和应用 | |
| CN110885312B (zh) | 一种靶向高尔基体的半胱氨酸荧光探针、制备方法与应用 | |
| CN108383819B (zh) | 一种基于香豆素酮醛的半胱氨酸荧光探针及其制备和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20230421 Address after: Room 613-C, 6th Floor, Block A, Building 1, No. 800, Naxian Road, Free Trade Experimental Zone, Pudong New Area, Shanghai, 200120 Patentee after: Shanghai Annengjian Biopharmaceutical Technology Co.,Ltd. Address before: No.85, Minglun street, Shunhe District, Kaifeng City, Henan Province Patentee before: Henan University |
|
| TR01 | Transfer of patent right |